Share-based Compensation (Tables)

9 Months Ended

Mar. 31, 2016

Share-based Compensation

Schedule of weighted average assumptions used to estimate fair values of the stock options granted and the estimated annual forfeiture rates used to recognize the associated compensation expense and the weighted average fair value of the options granted

	Nine months Ended
	March 31, 2016			March 31, 2015
Risk-free interest rate	1.7		%	1.7		%
Expected volatility	48.3		%	52.1		%
Expected dividend yield	0.0		%	0.0		%
Forfeiture rate	6.5		%	6.5		%
Expected term	5.2 years			5.5 years
Weighted average fair value	$	26.24		$	17.67

Summary of stock option award activity

(In thousands, except for weighted average price and life data)	Awards		Weighted- Average Exercise Price		Aggregate Intrinsic Value		Weighted Average Remaining Contractual Life (yrs.)
Outstanding at July 1, 2015	1,975		$	15.39
Granted	58		$	59.20
Exercised	(241	)	$	12.94	$	5,975
Forfeited, expired or repurchased	(42	)	$	32.61
Outstanding at March 31, 2016	1,750		$	16.76	$	12,369	6.5
Vested and expected to vest at March 31, 2016	1,721		$	16.46	$	12,341	6.5
Exercisable at March 31, 2016	1,193		$	10.55	$	11,508	5.7

Summary of nonvested restricted stock awards

(In thousands)	Awards		Weighted Average Grant - date Fair Value		Aggregate Intrinsic Value
Non-vested at July 1, 2015	98		$	37.83
Granted	141		$	55.95
Vested	(58	)	$	47.30	$	3,339
Forfeited	(8	)	$	47.62
Non-vested at March 31, 2016	173		$	48.97

Schedule of allocation of share-based compensation costs recognized in the Consolidated Statements of Operations by financial statement line item

	Three Months Ended				Nine months Ended
	March 31,				March 31,
(In thousands)	2016		2015		2016		2015
Selling, general and administrative expenses	$	1,511	$	1,195	$	6,891	$	3,805
Research and development expenses	195		133		584		390
Cost of sales	319		182		948		534
Total	$	2,025	$	1,510	8,423		$	4,729
Tax benefit at statutory rate	$	739	$	514	$	3,074	$	1,589